Research Article
Amino Acid Biosignature in Plasma among Ischemic Stroke Subtypes
Table 2
Figures of merit for PLS-DA models to discriminate chronic ischemic stroke from control/healthy plasma samples.
| |||||||||||||||||||||||||||||||||||||||||||||
Considering the detection of two control samples as outliers by the studentized y residuals at 95% confidence level, the EFR is 0.961 and 0.955 for the training and test sets, respectively. |